• Our postdoctoral trainee, Gregory Schwartz, will start his lab at the University of Toronto and Princess Margaret Cancer Center! Congratulations Gregory! You made us very proud (April 2021)!

  • Our study defining pan-cancer vascularization predictors is now online at the Jornal of Clinical Investigation. Congradulations to Ben, Gregory and our collaborators at the Stanger Lab (February 2021).

  • We welcome Aanchal Mongia, who is joining us after her PhD study at IIIT Delhi (October 2020).

  • Jingru Zhao joined the lab as a PhD student. Welcome Jingru! (November 2020).

  • We are excited to have Jingru Zhao in the lab for her rotation (August 2020).

  • Congratulations to Gregory and the rest of the lab for their recent paper published in Nature Methods (March 2020).

  • Yeqiao is presenting her latest data at Epigenetics & Immunology Symposium (March 2020).

  • Babak presented at the Weill Cornell (February 2020).

  • Join me to congratulate Jelena for joining Genentech as a research scientist. You will be missed (November 2019)!

  • Our R01 was scored in the NCI R37 fundable range (July 2019)!

  • Babak presented at the National Cancer Institute’s Genome Integrity Seminar Series (June 2019).

  • Congratulations to Yeqiao Zhou for passed her prelim with the highest score possible (May 2019).

  • Thank’s to Rutgers University’s Molecular and Biochemistry Society Seminar Series for hosting Babak (April 2019).

  • Babak presented at the Keystone 3D Genome meeting, March 2019, at Banff.

  • Congratulations to Jelena and Yeqiao! Their Molecular Cell paper entitled ‘‘Oncogenic Notch Promotes Long-Range Regulatory Interactions within Hyperconnected 3D Cliques’’ is now online.

  • The significance of our work entitled ‘‘Classes of ITD predict outcomes in AML patients treated with FLT3 inhibitors’’ was highlighted in a Clinical Cancer Research commentary entitled ‘‘Prognostic Models Turn the Heat(IT)up on FLT3-ITD-Mutated AML’’.

  • Gregory is presenting TooManyCells at Single Cell Biology Keystone Conference (January 2019).

  • Our preprint describing TooManyCells, a suite of graph-based scRNA-seq clustering and visualization tools, are now on Biorvix (January 2019).

  • Acceptance letter from Molecular Cell was Santa’s present for Jelena and Yeqaio. Have a wonderful 2019!

  • Our work entitled ‘‘Classes of ITD predict outcomes in AML patients treated with FLT3 inhibitors’’, has been accepted for publication in Clinical Cancer Research. A related video clip at the Penn Center for Precision Medicine (July 2018).

  • Congratulations to Gregory and the rest of the team for their interesting work, ‘‘Differential integration of transcriptome and proteome identifies pan-cancer prognostic biomarkers’’, published at the Frontiers in Genetics. (June 2018)

  • A preprint of the Gregory’s manuscript titled ‘‘Classes of ITD predict outcomes in patients with AML treated with FLT3 inhibitors’’ is now on bioRxiv. (June 2018)

  • The lab received the Susan G. Komen’s New Treatments for Drug-Resistant Breast Cancers award to study the mechanisms of epigenetic dysregulation in breast cancer. (April 2018).

  • Gregory recieved travel award to present his work at the Biology of Genomes Cold Spring Harbor Conference (April 2018).

  • Yeqiao joined the lab as a PhD student. Welcome Yeqiao! (March 2018)

  • A short video clip summarizing our AML precision prognostic project is posted at the Penn Center for Precision Medicine (January 2018).

  • Gregory’s software was highlighted at the Penn Medicine News

  • Abramson Family Cancer Research Institute funded our project to investigate the mechanism of epigenetic dysregulation in breast cancer. (November 2017)

  • Congratulations to Jelena and Yeqiao for their great work, ‘‘A unique B-cell regulome links Notch to downstream oncogenic pathways in small B-cell lymphoma’’, that was just accepted to Cell Reports. (September 2017)

  • Welcoming new member of the lab: 10X Genomics Chromium (August 2017)

  • Thanks to Jelena Petrovic and Yeqiao Zhou, our first map of breast cancer genome topology is ready! (June 2017)

  • Our lab is featured on the Pathology News.

  • Our paper titled '’Functional proteogenomics reveals biomarkers and therapeutic targets in lymphomas’’ is now online at PNAS.

  • Penn Center for Precision Medicine (PCPM) funded our proposal to study precision clinical decision making in targeted therapy of AML.

  • Thomas Campbell started his rotaion at the first week of May 2017.

  • Ben Kahn and Rohan Alur joined the lab for their independent studies in February 2017. Welcome Ben and Rohan.

  • The lab received the Cooper Scholar Award from the Abramson Cancer Center’s.

  • Our Penn Epigenetics Pilot Grant was renewed till 2018. Thanks The PENN Epigenetics Institute!

  • Institute for Translational Medicine and Therapeutics (ITMAT) supported our proposal for single cell epigenomics study of Leukemia.

  • After more than a year researching in the lab, Yeqiao Zhao was admitted to the Genetics & Epigenetics PhD program at UPenn. Congratulations Yeqiao!